NASDAQ:BSPM - Biostar Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.20 0.00 (0.00 %)
(As of 03/24/2019 08:05 AM ET)
Previous Close$0.20
Today's Range$0.20 - $0.20
52-Week Range$0.20 - $4.07
Volume11,842 shs
Average Volume4,064 shs
Market Capitalization$527,400.00
P/E RatioN/A
Dividend YieldN/A
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Receive BSPM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:BSPM



Sales & Book Value

Annual SalesN/A



Market Cap$527,400.00
Next Earnings DateN/A
OptionableNot Optionable

Biostar Pharmaceuticals (NASDAQ:BSPM) Frequently Asked Questions

What is Biostar Pharmaceuticals' stock symbol?

Biostar Pharmaceuticals trades on the NASDAQ under the ticker symbol "BSPM."

How were Biostar Pharmaceuticals' earnings last quarter?

Biostar Pharmaceuticals Inc (NASDAQ:BSPM) announced its earnings results on Wednesday, November, 15th. The company reported ($0.50) earnings per share for the quarter. During the same period in the previous year, the firm posted ($3.12) earnings per share. View Biostar Pharmaceuticals' Earnings History.

Has Biostar Pharmaceuticals been receiving favorable news coverage?

Media stories about BSPM stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Biostar Pharmaceuticals earned a media sentiment score of 2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term.

Who are some of Biostar Pharmaceuticals' key competitors?

What other stocks do shareholders of Biostar Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biostar Pharmaceuticals investors own include Cellectar Biosciences (CLRB), Zynga (ZNGA), Hudbay Minerals (HBM), Quantum (QTM), Synergy Pharmaceuticals (SGYP), Baytex Energy (BTE), Rigel Pharmaceuticals (RIGL), Sophiris Bio (SPHS), MEI Pharma (MEIP) and SLS International (SLS).

Who are Biostar Pharmaceuticals' key executives?

Biostar Pharmaceuticals' management team includes the folowing people:
  • Mr. Ronghua Wang, Chairman, CEO & Pres (Age 62)
  • Mr. Zhenghong Wang, Chief Operating Officer (Age 38)
  • Ms. Xiaojuan Zhai, Chief Financial Officer (Age 29)
  • Prof. Xiaohui Zheng, Chief Scientist (Age 50)
  • Ms. Shuang Gong, Director of Admin. & Sec. of Board (Age 51)

How do I buy shares of Biostar Pharmaceuticals?

Shares of BSPM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biostar Pharmaceuticals' stock price today?

One share of BSPM stock can currently be purchased for approximately $0.20.

How big of a company is Biostar Pharmaceuticals?

Biostar Pharmaceuticals has a market capitalization of $527,400.00.

What is Biostar Pharmaceuticals' official website?

The official website for Biostar Pharmaceuticals is

How can I contact Biostar Pharmaceuticals?

Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG SHAANXI PROVINCE F4, 712046. The company can be reached via phone at 011-86-29-3368-6638.

MarketBeat Community Rating for Biostar Pharmaceuticals (NASDAQ BSPM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  386
MarketBeat's community ratings are surveys of what our community members think about Biostar Pharmaceuticals and other stocks. Vote "Outperform" if you believe BSPM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSPM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel